Tumour angiogenesis and C-myc expression in breast carcinomas

Indian Journal of Pathology and Microbiology

Volumn 47, Issue 3, 2004, Pages 340-342

  Shanmugham, Rama ^a   Gopalan, Rama ^a,b   Shanthi, P ^a   Krishnan, K Baba ^a  

^a UNIVERSITY OF MADRAS   (India)

^b DRALMPGIBMS ^*  (India)

Author keywords

Angiogenesis; Breast carcinoma; c myc

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 ANTIBODY; CHROMOGENIC SUBSTRATE; EOSIN; FORMALDEHYDE; HEMATOXYLIN; PARAFFIN; PROTEIN ANTIBODY;

ARTICLE; BREAST CARCINOMA; CANCER CLASSIFICATION; CANCER GRADING; CANCER INVASION; CLINICAL ARTICLE; DENSITY; GENE AMPLIFICATION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICROVASCULATURE; MICROVESSEL DENSITY; MULTIGENE FAMILY; ONCOGENE C MYC; PROGNOSIS; STAINING; TUMOR VASCULARIZATION; BREAST TUMOR; FEMALE; GENETICS; MICROCIRCULATION; NEOVASCULARIZATION (PATHOLOGY); ONCOGENE MYC; PATHOLOGY; VASCULARIZATION;

BREAST NEOPLASMS; FEMALE; GENES, MYC; HUMANS; MICROCIRCULATION; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 33644808251     PISSN: 03774929     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Folkman J, Merler E, Abernathy C et al. Isolation of a tumor factor responsible for oncogenesis. J Exp Med 1971; 133:275-88.
2. Fox SB, Leek RD, Smith K, Hollyer J, Greenall M, Harris A. Tumor angiogenesis in node negative breast carcinomas - relationship with epidermal growth factor receptor, estrogen receptor and survival. Breast Cancer Res Treat 1994; 23:755-61.
3. Nikiforova IF. Amplification, rearrangement and expression of the c-myc and c-4A-ras 1 proto-oncogene in patients with breast cancer. Eksp onkol 1988; 10:17-20.
4. Pietilainen T, Lipponen P, Analtomaa S, Eskelinen M, Kaosma VM, Syrjanen K. Expression of c-myc proteins in breast cancer as related to established factors and survival. Anticancer Res 1995; 15:959-69.
5. De Jong JS, Van Diest PJ, Baak JPA. Hot spot microvessel density and the mitotic activity index are strong additional prognostic indicators in invasive breast cancer. Histopathology 2000; 36:306-12.
6. Bloom HJ, Richardson WW. Histological grading and prognosis in breast cancer. A study of 1049 cases of which 359 have been followed for 15 years. Br J Cancer 1957; 11:359-77.
7. Bosari S, Lee AK, De Lellis R, Wiley BD, Heatley GJ, Silverman ML. Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol 1992; 23:755-61.
8. Weidner N, Simple JP, Welch WR, Folkman J. Tumors angiogenesis and metastasis- correlation in invasive breast carcinoma. N Engl J Med 1991; 324:1-8.
9. Harris AL, Horak E, Leek R. Quantitative angiogenesis in human breast cancer- correlation with lymph node metastasis and assessment of vascular growth factors. Proc AACR 1992; 33:75.
10. Tyrinen O, Sjostrom J, von Bogulawski K et al. Tumour microvessel density as predictor of chemotherapy response in breast cancer patients. Br J Cancer 2002; 86:1905-8.
11. Karelia NH, Patel DD, Balar DB et al. Prognostic significance of tumour angiogenesis in advanced breast carcinoma: an Indian experience. Neoplasma 1997; 44(3):163-6.
12. Jensen HM, Chen I, Devault MR. Angiogenesis induced by "normal" human breast tissue: a probable marker for pre-cancer. Science 1982; 218:293-5.
13. Gasparini G, Weidner N, Bevilacqua P et al. Tumour microvessel density, p53 expression, tumour size and peritumoural lymphatic invasion are relevant prognostic markers in node negative breast carcinoma. J Clin Oncol 1994; 12:454-66.
14. Visscher D, Smilanetz S, Drozdowicz S, Wykes S. Prognostic significance of image morphometic microvessel enumeration in breast carcinoma. Anal Quant Cytol 1993; 15:88-92.
15. Goulding H, Rashid NFNA, Robertson JFR et al. Assessment of angiogenesis in breast cancer: an important factor in prognosis? Hum Pathol 1995; 26:1196-200.
16. Arora R, Joshi K, Nijhawan R, Radotra BD, Sharma SC. Angiogenesis is an independent prognostic indicator in node negative breast cancer. Anal Quant Cytol Histol 2002; 24(4):228-33.
17. Hansen S, Grabau DA, Sorensen FB, Bak M, Vach W, Rose C. Vascular grading of angiogenesis: prognostic significance in breast cancer. Br J Cancer 2000; 82:339-47.
18. Garte SJ. The c-myc oncogene in tumour progression. Crit Rev Oncog 1993; 4:435-49.
19. Watson PH, Safneck JR, Le K, Dubik D, Shiu RP. Relationship of c-myc amplification to progression of breast cancer from in situ to invasive tumour and lymphnode metastasis. J Natl Cancer Inst 1993; 85:902-7.
20. Kreipe H, Feist H, Fischer L et al. Amplification of c-myc but not of c-erb B2 is associated with high proliferative capacity in breast cancer. Cancer Res 1993; 53:1956-61.
21. Natley JM, Swallow BE, Brammar WJ, Whittaker JL, Walker RA. Alterations to either cerb B2(neu) or c-myc proto-oncogenes in breast carcinomas correlate with poor short term prognosis. Oncogene 1987; 1:423-30.
22. Brem SS, Jenson HM, Gullino PM. Angiogenesis as a tumor of preneoplastic lesions of human breast. Cancer 1978; 41:230.
23. Escot C, Theillet C, Lidereau R. Genetic alterations of the c-myc proto-oncogene(c-myc) in human primary breast carcinomas. Proc Natl Acad Sci USA 1986; 83:4834-8.
24. Donovan-Peluso M, Contento AM, Toban H, Ripepi B, Locker J. Oncogene amplification in breast cancer. Am J Pathol 1991; 138:835-45.